Photo from Yüksel Ürün/X
May 14, 2024, 13:15
Yüksel Ürün: A study from Sweden on over 350,000 men
Yüksel Ürün shared on X:
“A study from Sweden on over 350,000 men: .
- α1-adrenoceptor antagonists do not increase mortality from prostate cancer nor the risk of high-grade prostate cancer.
- However, these drugs are linked to a slight increase in overall prostate cancer incidence, especially lower-grade types. Possible detection bias?
- These medications include alfuzosin, doxazosin, terazosin, tamsulosin, and prazosin. These medications are FDA-approved to treat benign prostatic hyperplasia (BPH).“
Source: Yüksel Ürün/X
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes.
His dedication to patient care and research inspires positive change in the medical field.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 20:55
Nov 19, 2024, 15:20
Nov 19, 2024, 15:17
Nov 19, 2024, 15:14